<DOC>
	<DOCNO>NCT01138969</DOCNO>
	<brief_summary>Proton Pump Inhibitors ( PPI ) prevent recurrence peptic ulcer clopidogrel user .</brief_summary>
	<brief_title>Efficacy Proton Pump Inhibitor Prevention Clopidogrel-related Peptic Ulcer</brief_title>
	<detailed_description>The aim prospective , randomize study investigate efficacy PPI prevention ulcer recurrence clopidogrel user . We plan enroll 300 clopidogrel user without baseline gastroduodenal ulcer initial endoscopy . The patient randomly assign receive either ( 1 ) esomeprazole ( 20 mg qd ) plus clopidogrel ( 2 ) clopidogrel treatment alone 6 month . The ulcer recurrence rate treatment group compare .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>We plan enroll 300 clopidogrel user without baseline gastroduodenal ulcer initial endoscopy . The patient randomly assign receive either ( 1 ) esomeprazole ( 20 mg qd ) plus clopidogrel ( 2 ) clopidogrel treatment alone 6 month . 1.serious disease 2.refuse informed consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>proton pump inhibitor</keyword>
	<keyword>peptic ulcer</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>prevention</keyword>
</DOC>